CVE-2023-41088: Dexma Dexgate

Medium severity, CVSS 6.5. EPSS: 0.3% chance of exploitation in the next 30 days.

The affected product is vulnerable to a cleartext transmission of sensitive information vulnerability, which may allow an attacker with access to the network, where clients have access to the DexGate server, could capture traffic. The attacker can later us the information within it to access the application.

Affected products

• Dexma Dexgate: version 20130114 only

Published 2023-10-19. Last modified 2026-06-17.